TβRII, P-SMAD2 and P-AKT 473 levels were significantly higher in breast carcinomas, whereas the FAF1 level was significantly lower in cancer tissues compared with normal breast tissues (Fig. 8c). Here, TGFBR2 is linked to breast carcinoma.